These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8091362)

  • 21. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
    Janković B; Pasić S; Marković M; Veljković D; Milicić M
    Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
    Garrelts JC
    Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptive control of therapeutic drug regimens relations between clinical situations: outcomes and simulations using nonlinear dynamic models.
    Maire PH; Barbaut X; Thalabard JC; Vergnaud JM; Roux D; Roy M; Jelliffe RW
    Medinfo; 1995; 8 Pt 2():1111-5. PubMed ID: 8591382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetics changes of amikacin in severe burn patients at early stage].
    Hua R; Rong XZ; Zhang T; Yang RH
    Zhonghua Shao Shang Za Zhi; 2008 Feb; 24(1):33-5. PubMed ID: 18512557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assessment of pharmacokinetic parameters of amikacin in a group of neutropenic patients in onco-hematology].
    Pivot-Dumarest C; Deweerdt C; Troncy J; Sorensen P; Roux D; Maire P
    Pathol Biol (Paris); 1996 Apr; 44(4):299-305. PubMed ID: 8763595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
    Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
    Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis.
    Joly V; Pangon B; Vallois JM; Abel L; Brion N; Bure A; Chau NP; Contrepois A; Carbon C
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1632-9. PubMed ID: 3324957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amikacin pharmacokinetics and the effects of ambient temperature on the dosage regimen in ball pythons (Python regius).
    Johnson JH; Jensen JM; Brumbaugh GW; Boothe DM
    J Zoo Wildl Med; 1997 Mar; 28(1):80-8. PubMed ID: 9226620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Monitoring treatment with amikacin for urinary tract infections].
    Pieloch Z; Kowalczyk L; Adamska-Dyniewska H
    Pol Tyg Lek; 1993 May 17-31; 48(20-22):478-80. PubMed ID: 8170815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.
    Bondareva IB; Jelliffe RW; Sokolov AV; Tischenkova IF
    J Clin Pharm Ther; 2004 Apr; 29(2):105-20. PubMed ID: 15068399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetic parameters for Bayesian monitoring of amikacin therapy in intensive care unit patients.
    Debord J; Voultoury JC; Lachatre G; Gay C; Favereau JP; Gay R
    Eur J Clin Pharmacol; 1992; 43(4):435-6. PubMed ID: 1451727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and dosage regimens of amikacin in intensive care unit patients.
    Debord J; Voultoury JC; Lachatre G; Favereau JP; Gay R
    Int J Biomed Comput; 1994 Jun; 36(1-2):135-7. PubMed ID: 7927853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Amikacin pharmacokinetics in adults: a variability that question the dose calculation based on weight].
    Bourguignon L; Goutelle S; Gérard C; Guillermet A; Burdin de Saint Martin J; Maire P; Ducher M
    Therapie; 2009; 64(1):47-53. PubMed ID: 19463252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Calculation of the first dose of amikacine: evaluation of the current dosage recommendations].
    Jean-Bart E; Debeurme G; Ducher M; Bourguignon L
    Ann Pharm Fr; 2013 Jan; 71(1):7-12. PubMed ID: 23348851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased amikacin dosage requirements in burn patients receiving a once-daily regimen.
    Conil JM; Georges B; Breden A; Segonds C; Lavit M; Seguin T; Coley N; Samii K; Chabanon G; Houin G; Saivin S
    Int J Antimicrob Agents; 2006 Sep; 28(3):226-30. PubMed ID: 16908121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal delivery of aminoglycosides: amikacin transport and iontophoretic non-invasive monitoring.
    Nicoli S; Santi P
    J Control Release; 2006 Mar; 111(1-2):89-94. PubMed ID: 16413081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases.
    Peloquin CA; Berning SE; Nitta AT; Simone PM; Goble M; Huitt GA; Iseman MD; Cook JL; Curran-Everett D
    Clin Infect Dis; 2004 Jun; 38(11):1538-44. PubMed ID: 15156439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proximal tubule damage in patients treated with gentamicin or amikacin.
    Wiland P; Szechciński J
    Pol J Pharmacol; 2003; 55(4):631-7. PubMed ID: 14581723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetics of a single intramuscular dose of amikacin in red-tailed hawks (Buteo jamaicensis).
    Bloomfield RB; Brooks D; Vulliet R
    J Zoo Wildl Med; 1997 Mar; 28(1):55-61. PubMed ID: 9226617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.